• Wake Forest School of Medicine
    -
    Wake Forest University Health Sciences

    KL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Kirsten M. Wright, ND, MCR, MS from Oregon Health and Science University hosted by Wake Forest School of Medicine will present her research on "Using a Home-Based Monitoring Platform to Explore Real-World Routines and Nutrition Behavior in Older Adults at Risk

  • Wake Forest demonstrates how a health care system can more quickly turn research outcomes into patient care with a new blood pressure measurement protocol that may help prevent strokes and cardiovascular events.

  • Equipping Faculty at Wake Forest and Beyond When asked the vision behind CTSI’s Mentor Academy, Claudia Olivier, PhD responded: “Every mentor needs some level of training on how to be a good—a great—mentor.” Dr. Olivier serves as co-facilitator of the 6-month Mentor Academy cohorts alongside faculty Program Leader Debra Diz, PhD. Initially created for mid-career faculty, the Mentor Academy has

  • Wake Forest School of Medicine / Atrium Health: Research Symposium: COVID-19 Research Updates
    -
    Wake Forest University Health Sciences
    Wake Forest School of Medicine | Atrium Health Research Symposium: COVID-19 Research Updates Hosted by: John Walton Sanders III, MD, MPH Section Chief, Infectious Diseases, Wake Forest School of Medicine Michael Gibbs, MD, FACEP, FAAEM Chair, Emergency Medicine & Interim Vice President of Research, Atrium Health Sponsored by the Wake Forest CTSI Team Science Program Click here to learn more about
  • What's a Research Studio? CTSI’s Team Science Program created the Research Studio to meet the sometimes difficult-to-define needs around crafting grant proposals, finding collaborators, and fleshing out study teams. How will the study be designed? Is the hypothesis clear and succinct, yet robust enough to make a meaningful impact? How will the trial be implemented, measured, and finally translated

  • Taking Multi-Site Clinical Trials to the Next Level What Is TIN? TIN is the Trial Innovation Network, which streamlines clinical trials and harnesses the collective power of NCATS-funded institutions. As NCATS explains, TIN creates a “national network that focuses on operational innovation, excellence and collaboration and will leverage the expertise and resources of the CTSA Program.” Of the 62
  • Porphyrias Consortium (PC)

    The porphyrias are a group of rare, inherited disorders, each caused by a deficiency with one of eight enzymes necessary to produce heme, an important component of hemoglobin and other proteins. The porphyrias are classified as either acute hepatic (liver) or cutaneous (skin); the former is characterized generally by acute attacks of severe abdominal pain accompanied by nausea, vomiting and other

  • Nephrotic Syndrome Rare Disease Clinical Research Network III (NEPTUNE)

    Focal and Segmental Glomerulosclerosis, Minimal Change Disease and Membranous Nephropathy, presenting as Nephrotic Syndrome (NS), are a group of rare renal diseases that may cause serious complications and end-stage kidney disease, generating significant individual, societal and economic burdens. The Nephrotic Syndrome Study Network (NEPTUNE) brings together physician scientists at 26 sites in the

  • Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR)

    Eosinophilic esophagitis, eosinophilic gastritis, eosinophilic gastroenteritis and eosinophilic colitis are disorders in which a type of immune cells (called eosinophils) build up in the digestive tract, causing tissue damage to the esophagus, stomach or colon. These disorders are painful and lifelong, and they make it hard or impossible for people to eat many or all foods. The Consortium of

  • Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe)

    Amyotrophic lateral sclerosis (ALS) is a fatal disease that involves progressive death of motor nerves in the brain, brainstem and spinal cord. The disease is closely related to disorders such as primary lateral sclerosis, hereditary spastic paraplegia, progressive muscular atrophy and frontotemporal dementia. These diseases have shared genetic causes and underlying biology. They also have in

  • From Director Gary Rosenthal, MD, FACP, Tinsley R. Harrison Professor and Chair, Department of Internal Medicine. We are excited to announce the inaugural class of Academic Learning Health Systems Scholars at the Wake Forest School of Medicine. This NIH-funded postdoctoral training program (TL1 mechanism) is offered through the Wake Forest Clinical and Translational Science Institute (CTSI) and
  • Pioneering initiative will collect and share nationally data on clinical trial participants' perceptions throughout the United States. WINSTON SALEM, NOVEMBER 16, 2020: Wake Forest School of Medicine will serve as one of six sites nationally for the study Empowering the Participant Voice: Collaborative Infrastructure and Validated Tools for Collecting Participant Feedback to Improve the Clinical
  • 21 students awarded in Wake Forest School of Medicine's 2020 Medical Student Research Day.
  • Wake Forest University Health Sciences

    During this unprecedented time of the COVID-19 pandemic, Wake Forest’s Clinical and Translational Science Institute (CTSI) has navigated significant challenges the pandemic has presented to best support our research community. Our poster will communicate several areas where our CTSI has promoted COVID-19 research activities, facilitated the implementation of research new policies impacted by COVID

  • CTSI Methods Conference
    -
    Wake Forest University Health Sciences
    “Emerging Methods in Translational Science: Causal Inference” Nov. 13th, 2020 | 11am - 4pm EST | WebEx Catalyze the discussion and development of novel tools and methods for employing causal inference techniques in clinical and translational research. Facilitate mentoring relationships between early-career and senior faculty. Presented by Wake Forest CTSI BERD | Biostatistics, Epidemiology, &
  • Fetal Research and Therapy program at Wake Forest Institute for Regenerative Medicine
    -
    Wake Forest University Health Sciences
    From the Bench to the Bedside: Safely Translating Scientific Knowledge to Clinical Applications This two-day conference arranged by IFeTIS and virtually hosted by the Fetal Research and Therapy Center, Wake Forest Institute for Regenerative Medicine will cover the very latest research and progress in the areas of fetal immunology, transplantation, and gene therapy. ​
  • ATRN Virtual Conference 2020
    -
    Wake Forest University Health Sciences
    Save the Date for this Virtual Conference! September 22-23, 2020 - Tuesday, September 22: 9:45 AM - 12:20 PM - Wednesday, September 23: 9:45 AM - 12:45 PM The Wake Forest School of Medicine Clinical and Translational Science Institute (WFSM CTSI) will host the 10th Annual Summit on September 22-23, 2020. The Summit will be abbreviated and held virtually due to the COVID-19 pandemic. Upon
  • Duke, UNC, and Wake Forest Coronavirus Collaboration
    -
    Wake Forest University Health Sciences
    The Wake Forest Clinical and Translational Science Institute (CTSI) in conjunction with Duke and UNC would like to invite postdoctoral scholars and early career faculty involved in research to attend Research Resilience in the Age of COVID-19: Insights from Sponsors and Investigators on Thursday, July 9 from 2:00 - 4:30 pm. This virtual conference brings together researchers from all three
  • University Of North Carolina Chapel Hill
    Duke University
    Wake Forest University Health Sciences
    Medical University Of South Carolina
    ReGARDD provides academic researchers with the regulatory tools and resources necessary to successfully navigate the pathway from discovery to clinical implementation of new drugs, biologics and medical devices. Investigational New Drug or Biologic Investigational Device Exemption Educational Videos ReGARDD Sponsored Events Who We Are The Regulatory Guidance for Academic Research of Drugs and
  • Appalachian Translational Research Network Logo

    The Appalachian Translational Research Network (ATRN) is a 501©3 composed of academic institutions, community organizations, and individuals committed to translational research and training that addresses health disparities and inequities across the Appalachian region. Appalachia is a large, geographically-defined area of the eastern United States that has a history of significant health

  • The Wake Forest School of Medicine has made a considerable investment in a new Department of Implementation Science and will recruit five faculty, diverse in rank and discipline, into the department in the coming years. These individuals will be instrumental in operationalizing the vision and mission of the new department to become a national leader in dissemination and implementation research and
  • Wake Forest CTSI Nonhuman Primate Signature Program
    Wake Forest University Health Sciences

    Kylie Kavanagh, Matthew J. Jorgensen, J. Mark Cline, D. McClain The goal of Wake Forest (WF) Nonhuman Primate (NHP) Signature Program is to accelerate translational research by providing access to the ultimate translational animal model. NHP have served as an extremely successful preclinical platform that has allowed the bidirectional flow of knowledge from scientists to clinicians and back to